98 related articles for article (PubMed ID: 16290983)
1. A randomized trial in patients undergoing percutaneous coronary angioplasty: roxithromycin does not reduce clinical restenosis but angioplasty increases antibody concentrations against Chlamydia pneumoniae.
Kaehler J; Haar A; Schaps KP; Gaede A; Carstensen M; Schalwat I; Koester R; Laufs R; Meinertz T; Terres W
Am Heart J; 2005 Nov; 150(5):987-93. PubMed ID: 16290983
[TBL] [Abstract][Full Text] [Related]
2. Changes in antibody titers against Chlamydia pneumoniae after coronary angioplasty.
Yetkin G; Yetkin E; Aksoy Y; Gurbuz OA; Mert A
Int J Cardiol; 2004 Jun; 95(2-3):293-7. PubMed ID: 15193835
[TBL] [Abstract][Full Text] [Related]
3. Roxithromycin in prevention of acute coronary syndrome associated with Chlamydia pneumoniae infection: a randomized placebo controlled trial.
Leowattana W; Bhuripanyo K; Singhaviranon L; Akaniroj S; Mahanonda N; Samranthin M; Pokum S
J Med Assoc Thai; 2001 Dec; 84 Suppl 3():S669-75. PubMed ID: 12002908
[TBL] [Abstract][Full Text] [Related]
4. Combined periprocedural evaluation of CRP and TNF-alpha enhances the prediction of clinical restenosis and major adverse cardiac events in patients undergoing percutaneous coronary interventions.
Kubica J; Kozinski M; Krzewina-Kowalska A; Zbikowska-Gotz M; Dymek G; Sukiennik A; Piasecki R; Bogdan M; Grzesk G; Chojnicki M; Dziedziczko A; Sypniewska G
Int J Mol Med; 2005 Jul; 16(1):173-80. PubMed ID: 15942695
[TBL] [Abstract][Full Text] [Related]
5. High sensitivity C-reactive protein and immunoglobulin G against Chlamydia pneumoniae and chlamydial heat shock protein-60 in ischemic heart disease.
Jafarzadeh A; Esmaeeli-Nadimi A; Shariati M
Iran J Immunol; 2008 Mar; 5(1):51-6. PubMed ID: 18319525
[TBL] [Abstract][Full Text] [Related]
6. Association between eotaxin (CCL11), C-reactive protein, and antimicrobial antibodies in patients undergoing coronary angioplasty.
Kaehler J; Tuleweit A; Steven D; Krempl T; Haar A; Carstensen M; Koester R; Terres W; Meinertz T
J Investig Med; 2006 Dec; 54(8):446-54. PubMed ID: 17169268
[TBL] [Abstract][Full Text] [Related]
7. The relationship between Chlamydophila pneumoniae IgG titer and coronary atherosclerosis.
Kalay N; Kutukoglu I; Ozdogru I; Kilic H; Cetinkaya Y; Eryol NK; Karakaya E; Oguzhan A
Cardiol J; 2008; 15(3):245-51. PubMed ID: 18651417
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-3 is elevated in patients with coronary artery disease and predicts restenosis after percutaneous coronary intervention.
Rudolph T; Schaps KP; Steven D; Koester R; Rudolph V; Berger J; Terres W; Meinertz T; Kaehler J
Int J Cardiol; 2009 Mar; 132(3):392-7. PubMed ID: 18378332
[TBL] [Abstract][Full Text] [Related]
9. XS0601 reduces the incidence of restenosis: a prospective study of 335 patients undergoing percutaneous coronary intervention in China.
Chen KJ; Shi DZ; Xu H; Lü SZ; Li TC; Ke YN; Zhang MZ; Lu XY; Sun RY; You SJ
Chin Med J (Engl); 2006 Jan; 119(1):6-13. PubMed ID: 16454975
[TBL] [Abstract][Full Text] [Related]
10. Relationship between Chlamydia pneumoniae infection, inflammatory markers, and coronary heart diseases.
Romano Carratelli C; Nuzzo I; Cozzolino D; Bentivoglio C; Paolillo R; Rizzo A
Int Immunopharmacol; 2006 May; 6(5):848-53. PubMed ID: 16546716
[TBL] [Abstract][Full Text] [Related]
11. Chlamydia pneumoniae infection and restenosis in patients with coronary heart disease.
Krausse R; Leiendecker J; Herrmann G; Harder T; Ullmann U
Infection; 2003 Jun; 31(3):149-54. PubMed ID: 12789472
[TBL] [Abstract][Full Text] [Related]
12. Effect of a short antibiotic treatment with roxithromycin on circulating adhesion molecules after coronary stenting: a single-center pilot trial.
Vandoni P; Morelli B; Lazzati L; Citterio R; Poli A; Fetiveau R; D'Urbano M; Cafiero F; Viganò E; De Servi S
Ital Heart J; 2004 Sep; 5(9):667-72. PubMed ID: 15568594
[TBL] [Abstract][Full Text] [Related]
13. Treatment of Chlamydia pneumoniae infection with roxithromycin and effect on neointima proliferation after coronary stent placement (ISAR-3): a randomised, double-blind, placebo-controlled trial.
Neumann F; Kastrati A; Miethke T; Pogatsa-Murray G; Mehilli J; Valina C; Jogethaei N; da Costa CP; Wagner H; Schömig A
Lancet; 2001 Jun; 357(9274):2085-9. PubMed ID: 11445102
[TBL] [Abstract][Full Text] [Related]
14. Antibody levels against Chlamydia pneumoniae and outcome of roxithromycin therapy in patients with acute myocardial infarction. Results from a sub-study of the randomised Antibiotic Therapy in Acute Myocardial Infarction (ANTIBIO) trial.
Burkhardt U; Zahn R; Höffler U; Siegler KE; Frilling B; Weber M; Gottwik M; Wehr M; Seidel F; Rosocha S; Tebbe U; Senges J
Z Kardiol; 2004 Sep; 93(9):671-8. PubMed ID: 15365734
[TBL] [Abstract][Full Text] [Related]
15. Coronary angioplasty induces rise in Chlamydia pneumoniae-specific antibodies.
Tiran A; Tio RA; Ossewaarde JM; Tiran B; den Heijer P; The TH; Wilders-Truschnig MM
J Clin Microbiol; 1999 Apr; 37(4):1013-7. PubMed ID: 10074519
[TBL] [Abstract][Full Text] [Related]
16. Chlamydia pneumoniae antibodies and inflammatory reaction in patients with ischemic heart disease.
Zdrenghea D; Bodizs G; Taloş C; Stanciu A; Roşu R; Timiş D; Aluaş D
Rom J Intern Med; 2000-2001; 38-39():51-7. PubMed ID: 15529571
[TBL] [Abstract][Full Text] [Related]
17. Correlation of hyperhomocysteinaemia and Chlamydia pneumoniae IgG seropositivity with coronary artery disease in a general population.
Nabipour I; Vahdat K; Jafari SM; Amiri M; Shafeiae E; Riazi A; Amini AL; Pazoki R; Sanjdideh Z
Heart Lung Circ; 2007 Dec; 16(6):416-22. PubMed ID: 17974477
[TBL] [Abstract][Full Text] [Related]
18. Periprocedural soluble P- and E-selectin levels fail as predictors of clinical restenosis in patients treated with elective coronary stenting.
Kozinski M; Kubica J; Sukiennik A; Zbikowska-Gotz M; Krzewina-Kowalska A; Radomski M; Rychter M; Bialoszynski T; Jablonski M; Demidowicz K; Grzesk G; Bogdan M; Chojnicki M; Grabczewska S; Dziedziczko A
Int J Mol Med; 2007 Jan; 19(1):187-95. PubMed ID: 17143564
[TBL] [Abstract][Full Text] [Related]
19. Trial of roxithromycin in subjects with asthma and serological evidence of infection with Chlamydia pneumoniae.
Black PN; Blasi F; Jenkins CR; Scicchitano R; Mills GD; Rubinfeld AR; Ruffin RE; Mullins PR; Dangain J; Cooper BC; David DB; Allegra L
Am J Respir Crit Care Med; 2001 Aug; 164(4):536-41. PubMed ID: 11520711
[TBL] [Abstract][Full Text] [Related]
20. Interaction between Chlamydia pneumoniae seropositivity, inflammation and risk factors for atherosclerosis in patients with severe coronary stenosis.
Yavuz MT; Yavuz O; Yazici M; Guler S; Ozhan H; Albayrak S; Coskun A
Scand J Clin Lab Invest; 2006; 66(6):523-34. PubMed ID: 17000560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
